Scopio Labs, a Tel Aviv, Israel-based developer of an advanced digital microscopy and diagnostics platform, raised $7m in funding.
Equity crowdfunding platform OurCrowd will invest $2.5m in the round while other backers have not been disclosed.
The company will use the funds to expand the team with computer vision experts, physicists and software developers.
Founded in 2015 by Itai Hayut and Erez Na’aman, Scopio Labs develops digital microscopes, based on computational imaging innovations, as well as a suite of dedicated image analysis tools, which enable clinical and research improvements in diverse areas such as cancer, hematology and cytology, while powering further innovation in areas such as academic research and drug discovery.
FinSMEs
24/05/2017